Bortezomib and Dexamethasone in Previously Untreated Multiple Myeloma Associated with Renal Failure and Reversal of Renal Failure

Publisher： Karger

E-ISSN： 1421-9662|116|4|255-258

ISSN： 0001-5792

Source： Acta Haematologica, Vol.116, Iss.4, 2006-11, pp. : 255-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bortezomib with Thalidomide plus Dexamethasone Compared with Thalidomide plus Doxorubicin and Dexamethasone as Induction Therapy in Previously Untreated Multiple Myeloma Patients

By  

Acta Haematologica, Vol. 129, Iss. 1, 2012-10 ,pp. : 35-39

Karger

Access to resources Recommend Favorite

Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5‐year follow‐up

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 171, Iss. 3, 2015-11 ,pp. : 344-354

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evolving Treatments in Multiple Myeloma Patients with Renal Failure

By  

Reviews on Recent Clinical Trials, Vol. 9, Iss. 4, 2014-12 ,pp. : 276-279

Bentham Science Publishers

Access to resources Recommend Favorite

Demonstration of the cause of acute renal failure in a case of IgD multiple myeloma

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 2, 2015-01 ,pp. : 162-162

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ibandronate for the Treatment of Hypercalcemia or Nephrocalcinosis in Patients with Multiple Myeloma and Acute Renal Failure: Case Reports

By  

Acta Haematologica, Vol. 116, Iss. 3, 2006-10 ,pp. : 165-172

Karger

Access to resources Recommend Favorite